• Latest Med News

Research Unveils New Diagnosis Option for Dementia

By: Sai Srihaas Potu

The prevalence of dementia is estimated to double every 20 years from 46.8 million in 2015 to nearly 131.5 million by 2050. The natural history of different dementias, the quality of diagnosis and care, the use of community services and long-term care, the costs of care, and the effects on caregivers at a population level are largely unknown or rely on extrapolations from smaller samples.

There is anticipated growth in the number of people needing diagnostic evaluations, treatments, and care. Ensuring a consistent and contemporary understanding of dementia across all of these groups has become a critical issue. The prevalence of dementia is increasing worldwide commensurate with population aging, yet treatments are generally ineffective at slowing progression. Evidence increasingly supports the terminal course of dementia and requirements for higher levels of care in the later stages of the condition.

The risk of developing dementia increases markedly when a person is diagnosed with mild cognitive impairment, a noticeable and measurable decline in intellectual abilities that does not seriously interfere with daily life. But physicians have no reliable way to predict which people with mild cognitive impairment are likely to be in the 5 to 10 percent a year who progress to dementia.

In a proof-of-concept study, Johns Hopkins investigators analyzed records of 528 people, age 60 and over, who were referred to the Johns Hopkins Medical Psychology Clinic for cognitive testing as part of a dementia work-up between 1996 and 2004. The results were compared to those of 135 healthy older adults who participated in a study of normal aging. Both groups completed tests of memory, language, attention, processing speed, and drawing abilities from which 13 scores were recorded.

Using scores obtained from cognitive tests, Johns Hopkins researchers developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer’s disease, the most common form of dementia.

Since each person is naturally more skillful in some areas than in others, the scores of healthy adults showed a symmetrical, bell-shaped range: most of the scores were in the medium range, a few were a bit higher, and a few were a bit lower. By grouping the patients into cohorts based on the severity of their dementia, the researchers found a trend in the test scores that is likely to mimic the deterioration of an individual’s scores over time.

At the outset, Alzheimer’s disease subtly disrupts some mental abilities, while leaving others intact. Thus, well before a person develops clear cognitive impairment, his or her performance declines slightly on a few measures. When shown on a graph, these changes cause a healthy symmetric, bell-shaped curve to shift, and become asymmetrical.

Regardless of how low a person’s test scores were, the researchers determined that lopsidedness in their score distribution correlated with dementia. They predicted that people with low scores that were evenly distributed were not likely to develop dementia. But those with clearly lopsided test score distributions on the 13 measures administered were already experiencing varying levels of dementia. Since these declines can be subtle, the researchers also increased the precision of cognitive testing by accounting for the effects of age, sex, race, and education on test performance.

The challenge for doctors is that most normal, healthy people will produce a few low scores on cognitive testing. That makes it nearly impossible to know at the outset whether a patient who reports forgetfulness and produces one or two low scores has a benign form of mild cognitive impairment or is in the earliest stage of dementia. As a result, doctors often tell such patients to return for follow-up testing in a year or two. But if future research confirms it, this new statistical model could help doctors get the prognosis right earlier in the disease, at the first visit, and start treating patients accordingly.

Doctors could use the new model to reassure patients who are not at risk of dementia, while fast-tracking interventions for those who are. Because there currently are no effective treatments for Alzheimer’s disease, those likely headed that way could be counseled to take the good time they have to organize their affairs and do things they have always wanted to do. They also could be fast-tracked into clinical trials of medications to slow the progression of dementia.

Recent failures of drugs in late-stage clinical trials for Alzheimer’s disease have been a real blow, but new treatments are being developed. The new way of reading existing test scores follows a 2008 study by the same researchers showing that one of every six healthy adults scored poorly on two or more of 10 tests in a brief cognitive battery, even though there was nothing wrong with them.

The main reason it is difficult to tell whether older people have benign mild cognitive impairment or not is that they are not routinely screened for cognitive impairment. A visit to a specialist comes only after someone has noticed symptoms, and then cognitive testing is interpreted without the benefit of a baseline assessment. What would solve this problem, would be for everyone over the age of 55 to get routine neurocognitive testing every five years.

People experiencing dementia are encountered in the community, residential aged care facilities, and hospitals. Due to the growing prevalence of people with the condition in the community, the need for knowledge about dementia has never been greater. Researchers need to continue to conduct research on this psychological disorder in order to provide a better diagnosis and create more reliable treatment options.


1. Gila Z. Reckess, Mark Varvaris, Barry Gordon, David J. Schretlen. Within-Person Distributions of Neuropsychological Test Scores as a Function of Dementia Severity. Neuropsychology. 2013.

2. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimer’s and Dementia Journal. 2008.

3. Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, Przybelski SA. Antemortem differential diagnosis of dementia pathology using structural MRI: differential-STAND. Neuroimage. 2011.


© 2019 by Latest Med News